Trial Profile
A Rollover Study to Provide Chronic T-1249 to Patients Who Completed Study T1249-102
Status:
Active, no longer recruiting
Phase of Trial:
Phase I/II
Latest Information Update: 12 Oct 2005
Price :
$35
*
At a glance
- Drugs Tifuvirtide (Primary)
- Indications HIV infections
- Focus Adverse reactions; Therapeutic Use
- 12 Oct 2005 New trial record.